HOPE PITTMAN: Open Payments
NPI 1861087215 · PETAL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,297 in 53 payments from 22 companies in 2025. Trend: 2023 $846 · 2024 $733 · 2025 $1,297
Food & beverage: $1,121Travel & lodging: $141Education: $36
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $400 |
| Janssen Biotech, Inc. | 8 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $133 |
| Sumitomo Pharma America, Inc. | 5 | $97 |
| Kerecis Limited | 3 | $54 |
| ACCORD HEALTHCARE, INC. | 2 | $50 |
| COLOPLAST CORP | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| UROGEN PHARMA, INC. | 1 | $36 |
| TOLMAR, INC. | 2 | $32 |
Products named: INTERSTIM, ERLEADA, Nubeqa, GEMTESA, Kerecis SurgiClose, Camcevi, ADSTILADRIN, ZUSDURI.
Industry payments across MS — which companies pay providers there.
